These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35132908)

  • 1. Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.
    Conti F; Gottardi F; Moratti M; Belotti T; Ferrari S; Selva P; Bassi M; Zama D; Pession A
    Platelets; 2022 Jul; 33(5):801-806. PubMed ID: 35132908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
    Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded utilization of rituximab in paediatric cardiac transplant patients.
    Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
    J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.
    Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F
    Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy.
    Knight T; Ravindranath Y; Callaghan MU
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e110-e113. PubMed ID: 30299351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib treatment of steroid-refractory Evans syndrome in children.
    Beydoun SB; Persaud Y; Lafferty J; Callaghan MU; Savaşan S
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28725. PubMed ID: 32969165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
    Jasinski S; Weinblatt ME; Glasser CL
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):420-424. PubMed ID: 28267088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.
    Beckman JD; Rollins-Raval MA; Raval JS; Park YA; Mazepa M; Ma A
    Am J Ther; 2018; 25(2):e270-e272. PubMed ID: 29293474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ITP and AIHA in CVID: A systematic literature review].
    Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
    Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
    Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
    Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
    Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia.
    Muhsen IN; Alahmari A; Alnahedh M; Alkhudair NA; Samarkandi H; El Fakih R
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):251-254. PubMed ID: 31202670
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature.
    Yassa G; Shakir AR; Jagarlamudi K; Yassa AE
    J Oncol Pharm Pract; 2021 Jan; 27(1):253-257. PubMed ID: 32611269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I manage Evans Syndrome and AIHA cases in children.
    Miano M
    Br J Haematol; 2016 Feb; 172(4):524-34. PubMed ID: 26625877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.